MPNs as Inflammatory Diseases: The Evidence, Consequences, and Perspectives

Mediators of Inflammation - Egypt
doi 10.1155/2015/102476
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Exercise in Patients With Inflammatory Bowel Diseases: Current Perspectives

Clinical and Experimental Gastroenterology
Gastroenterology
2017English

The Gut Microbiota as Target for Innovative Drug Development: Perspectives and a Case Study of Inflammatory Bowel Diseases

2011English

The Role of Dietary Factors in Inflammatory Bowel Diseases: New Perspectives

Journal of Digestive Diseases
Gastroenterology
2018English

Biosimilars: Concept, Current Status, and Future Perspectives in Inflammatory Bowel Diseases

Intestinal Research
Gastroenterology
2020English

The cAMP Pathway as Therapeutic Target in Autoimmune and Inflammatory Diseases

Frontiers in Immunology
AllergyImmunology
2016English

Environment and the Inflammatory Bowel Diseases

Canadian Journal of Gastroenterology
2013English

Taurine and Inflammatory Diseases

Amino Acids
Organic ChemistryBiochemistryClinical Biochemistry
2012English

Catestatin as a Target for Treatment of Inflammatory Diseases

Frontiers in Immunology
AllergyImmunology
2018English

Calprotectin as a Diagnostic Tool for Inflammatory Bowel Diseases

Biomedical Reports
GeneticsPharmacologyMolecular BiologyBiochemistryNeuroscienceMedicineToxicologyPharmaceutics
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy